Commentary: Imidazoline receptors

Neurochemistry International

Volumn 30, Issue 1, 1997, Pages 3-7

  Bousquet, P ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANTIHYPERTENSIVE AGENT; CATECHOLAMINE; CORBADRINE; IMIDAZOLINE; RECEPTOR; CLONIDINE; DRUG RECEPTOR; IMIDAZOLE DERIVATIVE; IMIDAZOLINE RECEPTORS;

ANTIHYPERTENSIVE ACTIVITY; BINDING AFFINITY; BINDING SITE; LATERAL RETICULAR NUCLEUS; LOCUS CERULEUS; POTENTIOMETRY; PRIORITY JOURNAL; RECEPTOR BINDING; SHORT SURVEY; SOLITARY TRACT NUCLEUS; STRUCTURE ACTIVITY RELATION; ANIMAL; BLOOD PRESSURE; BRAIN; DRUG EFFECT; HUMAN; METABOLISM; MITOCHONDRION; PHYSIOLOGY; REVIEW; ULTRASTRUCTURE;

ANIMALS; BLOOD PRESSURE; BRAIN; CLONIDINE; HUMANS; IMIDAZOLES; MITOCHONDRIA; RECEPTORS, DRUG;

EID: 0030637031     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00039-3     Document Type: Note

References (68)

1. 3H]-Cirazoline as a tool for the characterization of imidazoline sites. N.Y. Acad. Sci. 763, 112-124.
2. Atlas, D. and Burstein, Y. (1984) Isolation of an endogenous clonidine-displacing substance from rat brain. FEBS Lett. 170, 387-390.
3. Atlas, D. and Burstein, Y. (1984) Isolation and partial purification of a clonidine displacing endogenous brain substance. Eur. J. Biochem. 144, 287-293.
4. Bennaï, F., Greney, H., Stutzmann, J., Bousquet, P. and Dontenwill, M. (1995) Development of anti-idiotypic antibodies specific for the human cerebral imidazoline receptor. N.Y. Acad. Sci. 763, 140-148.
5. Bousquet, P. and Guertzenstein, P. G. (1973) Localization of the central cardiovascular action of clonidine. Br. J. Pharmac. 49, 573-579.
6. Bousquet, P., Feldman, J., Bloch, R. and Schwartz, J. (1981) The nucleus reticularis lateralis a region highly sensitive to clonidine. Eur. J. Pharmac. 69, 389-392.
7. Bousquet, P., Feldman, J. and Schwartz, J. (1984) Central cardiovascular effects of α-adrenergic drugs: Difference between catecholamines and imidazolines. J. Pharmac. Exp. Ther. 230, 232-236.
8. Bousquet, P., Feldman, J. and Schwartz, J. (1985) The medullary cardiovascular effects of imidazolines and some GABA analogues: a review. J. Auton. Nerv. Syst. 14, 263-270.
9. Bousquet, P., Feldman, J. and Atlas, D. (1986) An endogenous, non-catecholamine clonidine antagonist increases mean arterial blood pressure. Eur. J. Pharmac. 124, 167-170.
10. Bousquet, P., Greney, H., Bennai, F., Feldman, J., Stutzmann, J., Belcourt, A. and Dontenwill, M. (1995) Imidazoline receptors and cardiovascular regulations: a statement. N.Y. Acad. Sci. 763, 526-530.
11. Bricca, G., Dontenwill, M., Molines, A., Feldman, J., Belcourt, A. and Bousquet, P. (1988) Evidence for the existence of a homogenous population of imidazoline receptors in the human brainstem. Eur. J. Pharmac. 150, 401-402.
12. Bricca, G., Dontenwill, M., Molines, A., Feldman, J., Tibiriça, E., Belcourt, A. and Bousquet, P. (1989) The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. Eur. J. Pharmac. 162, 1-9.
13. Bricca, G., Dontenwill, M., Molines, A., Feldman, J., Tibiriça, E., Belcourt, A. and Bousquet, P. (1989) Rilmenidine selectivity for imidazoline receptors in human brain. Eur. J. Pharmacol. 163, 373-377.
14. 3H]idazoxan in the human cerebral cortex. J. Neurochem. Int. 2, 153-163.
15. 3H]clonidine. Eur. J. Pharmac. - Molec. Pharmacol. Sect. 266, 25-33.
16. 2-imidazoline sites. J. Pharmacol. Exp. Ther. 272, 681-687.
17. Coupry, I., Podevin, R. A., Dausse, J. P., Parini, A. (1987) Evidence for imidazoline binding sites in basolateral membranes from rabbit kidney. Biochem. Biophys. Res. Commun. 147, 1055-1060.
18. 2-adrenoceptors affect sleep and arousal mechanisms. Br. J. Pharmac. 90, 675-685.
19. Delbarre, B. and Schmitt, H. (1971) Sedative effects of a a-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Eur. J. Pharmac. 13, 356-363.
20. 2-adrenoceptors in the human central nervous system. Neurosci. 59(3), 589-598.
21. Dontenwill, M., Bricca, G., Molines, A., Belcourt, A. and Bousquet, P. (1987) A polyclonal antibody raised against clonidine: a model for the specific imidazoline receptor. Eur. J. Pharmac. 137, 143-144.
22. Dontenwill, M., Bricca, G., Molines, A., Bousquet, P. and Belcourt, A. (1988) Production and characterization of anticlonidine antibodies not cross-reacting with catecholamines. Eur. J. Pharmacol. 149, 249-255.
23. Dontenwill, M., Molines, A., Bricca, G., Stutzman, J., Kempf, J., Belcourt, A. and Bousquet, P. (1992) Production and characterization of an iminoimidazolidine specific monoclonal antibody using p-aminoclonidine as antigen. Life Sci. 50, 1859-1868.
24. Dontenwill, M., Molines, A., Verdun, A., Bricca, G., Laurent, S. and Bousquet, P. (1993) A circulating substance cross reacting with anti-imidazoline antibodies: detection in serum in relation with essential hypertension. J. Clin. Invest. 93, 1068-1072.
25. Ernsberger, P. R., Meeley, M. P., Reis, D. J. (1988) An endogenous substance with clonidine like properties: selective binding to imidazole sites in the ventrolateral medulla. Brain Res. 441, 309-318.
26. 2-adrenoceptors in the ventrolateral medulla. Eur. J. Pharmac. 134, 1-13.
27. Escriba, P. V., Sastre, M., Wang, H., Regunathan, S., Reis, D. J., Garcia-Sevilla J. A. (1994) Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissues. Neurosci. Lett. 178, 81-84.
28. Feldman, J., Tibiriça, E., Bricca, G., Dontenwill, M., Belcourt, A. and Bousquet, P. (1990) Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit. Br. J. Pharmac. 100, 600-604.
29. Greney, H., Bennaï, F., Molines, A., Belcourt, A., Dontenwill, M. and Bousquet P. (1994) Isolation of a human cerebral imidazoline-specific binding protein. Eur. J. Pharmac. 265, R1-R2.
30. 3H] clonidine. Neurochem. Int. 25, 183-191.
31. Haeusler, G. (1974) Clonidine-induced inhibition of sympathetic nerve activity: No indication for a central pre-synaptic or an indirect sympathomimetic mode of action. Naunyn Schmiedeberg's Arch. Pharmac. 286, 97-111.
32. Haeusler, G. and Finch, L. (1972) On the nature of the central hypotensive effect of clonidine and α-methyldopa. J. Pharmacol. (Paris) 3, 544-545.
33. Ivkovic, B., Bakthavachalam, V., Zhang, W., Parini, A., Diz, D., Bosch, S., Singh, I., Neumeyer, J. L., Lanier, S. M. (1994) Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain and kidney. J. Pharmacol. Exp. Ther. 46, 15-23.
34. Kobinger, W. and Pichler, L. (1974) Evidence for direct alpha-adrenoceptor stimulation of effector neurons in cardiovascular centers by clonidine. Eur. J. Pharmacol. 27, 151-154.
35. Kobinger, W. and Pichler, L. (1975) The central modulatory effect of clonidine on the cardiodepressor reflex after suppression of synthesis and storage of noradrenaline. Eur. J. Pharmacol. 30, 56-62.
36. Kobinger, W. (1978) Central alpha-adrenergic systems as targets for hypotensive drugs. Rev. Physiol. Biochem. 81, 39-100.
37. Lachaud-Pettiti, V., Podevin, R. A., Chretien, I. and Parini, A. (1991) Imidazoline-guanidinium receptive sites in basolateral membranes from human kidney. Eur. J. Pharmacol. 206, 23-31.
38. 2-adrenoceptors in rabbit adipocyte membranes. Eur. J. Pharmacol. 159, 199-203.
39. Lanier, S. M., Ivkovic, B., Singh, I., Neumeyer, J. L., Bakthavachalam, V. (1993) Visualization of multiple imidazoline/guanidinium receptive sites. J. Biol. Chem. 268, 16047-16051.
40. Li, G., Regunathan, S., Barrow, C. J., Eshraghi, J., Cooper, R. and Reis, D. J. (1994) Agmatine: an endogenous clonidine displacing substance in the brain. Science 263, 966-969.
41. Limon, I., Coupry, I., Lanier, S. M., Parini, A. (1992) Purification and characterization of mitochondrial imidazoline-guanidinium receptive site from rabbit kidney. J. Biol. Chem. 267, 21645-21649.
42. Meeley, M. P., Ernsberger, P. R., Granata, A. R., Reis, D. J. (1986) An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla. Life Sci. 38, 1119-1126.
43. Michel, M. C., Insel, P. A. (1989) Are there multiple imidazoline binding sites?. Trends Pharmac. Sci. 10, 342-344.
44. 3H]RX 821002 (2-methoxy idazoxan) in the human and rat brains. J. Pharmac. Exp. Ther. 264, 1187-1197.
45. Molderings, G. J., Hentrich, F., Göthert, M. (1991) Pharmacological characterization of the imidazoline receptor which mediates inhibition of noradrenaline release in the rabbit pulmonary artery. Naunyn Schmiedeberg's Arch. Pharmacol. 344, 630-638.
46. Nutt, D. J., French, N., Handley, S., Hudson, A., Husbands, S., Jackson, H., Jordan, S., Lalies, M.D., Lewis, J., Lione, L., Mallard, N. and Pratt, J. (1995) Functional studies of specific imidazoline-2 receptors ligands. N.Y. Acad. Sci. 763, 125-139.
47. 2-adrenergic receptor. J. Biol. Chem. 264, 11874-11878.
48. Piletz, J. E., Sletten, K. (1993) Nonadrenergic imidazoline binding sites on human platelets. J. Pharmac. Exp. Ther. 267, 1493-1502.
49. 2-adrenergic receptors in bovine cerebral cortex. Fund. Clin. Pharmacol. 6, 53S.
50. Regunathan, S., Meeley, M. P., Reis, D. J. (1993) Expression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal. Biochem. Pharmacol. 45, 1667-1675.
51. 2-adrenergic effects of phenylethylamines and imidazolines. Eur. J. Pharmacol. 86, 471-475.
52. 2 with monoamine oxidase-Bsites. J. Neurochem. 61, 881-889.
53. Schmitt, H. (1977) The pharmacology of clonidine and related products. In Handbook of Experimental Pharmacology (Gross, F., Ed.), pp. 299-396. Vol. 39. Anti-hypertensive Agents. Springer, Berlin.
54. Starke, K., Montel, H., Gayk, W. and Merker, R. (1974) Comparison of the effects of clonidine on pre-and post-synaptic adrenoceptors in the rabbit pulmonary artery, α-sympathomimetic inhibition of neurogenic vasoconstriction. Naunyn Schmiedeberq's Arch. Pharmacol. 285, 133-150.
55. Starke, K. (1981) Alpha-adrenoceptors subclassification. Rev. Physiol. Biochem. Pharmacol. 88, 199-236.
56. 2-Imidazoline binding sites on monoamine oxidases. J. Biol. Chem. 270, 9856-9861.
57. Tibiriça, E., Mermet, C., Feldman, J., Gonon, F. and Bousquet, P. (1989) Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach. J. Pharmac. Exp. Ther. 250, 642-647.
58. Tibiriça, E., Feldman, J., Mermet, C., Gonon, F. and Bousquet, P. (1991) An imidazoline specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan. J. Pharmac. Exp. Ther. 256, 606-613.
59. Tibiriça, E., Feldman, J., Mermet, C., Monassier, L., Gonon, F. and Bousquet, P. (1991) Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors. Eur. J. Pharmacol. 209, 213-221.
60. 2-adrenoceptors: classification, localization, mechanisms and target for drugs. J. Med. Chem. 25, 1389-1401.
61. Wang, H., Regunathan, S., Meeley, M. P., Reis, D. J. (1992) Isolation and characterization of imidazoline receptor protein from bovine adrenal chromaffin cells. Mol. Pharmacol. 42, 792-801.
62. Warnke, E. and Hoefke, W. (1977) Influence of central pre-treatment with 6-hydroxydopamine on the hypotensive effect of clonidine. Arzneim. Forsch. 27, 2311-2313.
63. Wikberg, J. E. S. (1989) High affinity binding of idazoxan to a non-catecholaminergic binding site in the central nervous system: description of a putative idazoxan-receptor. Pharmacol. Toxicol. 64, 152-155.
64. Wikberg, J. E. S. and Uhlen, S. (1990) Further characterization of the guinea pig cerebral cortex idazoxan receptor, solubilization distinction from the imidazoline site, and demonstration of cirazoline as an idazoxan receptor selective drug. J. Neurochem. 55, 192-203.
65. Wolf, D. L., Mohrland, J. S. (1984) Lateral reticular formation as a site for morphine and clonidine induced hypertension. Eur. J. Pharmacol. 98, 93-95.
66. 3H]idazoxan in the smooth muscle of rabbit urethra. Eur. J. Pharmacol. 154, 209-212.
67. Zandberg, P. and De Jong, W. (1977) Alpha-methyl-noradrenaline induced hypotension in the nucleus tractus solitarii of the rat. Neuropharmacol. 16, 219-222.
68. Zweiten, P. A. (1977) Interactions interfering with central adrenoreceptor activity and hypotension of centrally acting antihypertensive agents. In Hypertension and Brain Mechanisms (de Jong, W., Provoost, A.P. and Shapiro, A., Eds), pp. 385-396. Elsevier, Amsterdam.